| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b04f8b3754086ae41a3b0ea58539e4a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-90 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6939
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0018 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-716
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
| filingDate |
2017-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c49d1dc6ce988d7dcae4448dfdf86d0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cf0dc391a686cc37c42d6856462a266
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcd19c6784644442b571b5a1473570e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70eb9c15d22683f9d766737003131478 |
| publicationDate |
2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112018072452-A2 |
| titleOfInvention |
glycogen and phytoglycogen nanoparticles as immunosuppressive compounds, and compositions and methods for their use |
| abstract |
The present invention relates to compounds and compositions comprising glycogen or phytoglycogen nanoparticles which are provided to suppress the innate immune responses of interferon type i. glycogen or phytoglycogen nanoparticles in the composition are suitably catalyzed, in one embodiment, functionalized with an amino group. |
| priorityDate |
2016-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |